Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario
Mamdani M, Warren L, Kopp A, Paterson JM, Laupacis A, Bassett K, Anderson GM. CMAJ. 2006; 175(12):1535-8.
Publications
Clinical consequences of generic warfarin substitution: an ecological study
Paterson JM, Mamdani M, Juurlink DN, Naglie G, Laupacis A, Stukel TA. JAMA. 2006; 296(16):1969-72.
Case selection for statins was similar in two Canadian provinces: BC and Ontario
Paterson JM, Carney G, Anderson GM, Bassett K, Naglie G, Laupacis A; BC-Ontario Pharmacosurveillance for Decision-making Collaborative. J Clin Epidemiol. 2007; 60(1):73-8. Epub 2006 Sep 7.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Paterson JM, Laupacis A, Bassett K, Anderson GM; BC-Ontario Pharmacosurveillance for Decision-Making Collaborative. Health Aff. 2006; 25(5):1436-43.
Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
Jackevicius CA, Paterson JM, Naglie G. Pharmacoepidemiol Drug Saf. 2007; 16(2):207-15.
Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach
Laupacis A, Paterson JM, Mamdani M, Rostom A, Anderson GM. CMAJ. 2003; 169(11):1167-70.
What Effects do Provincial Drug Plan Coverage Policies for New Drugs have on Patterns of Use and Cost?
Use of antidepressants among Canadian workers receiving depression-related short-term disability benefits
Dewa CS, Hoch JS, Goering P, Lin E, Paterson M. Psychiatr Serv. 2003; 54(5):724-9.
Primary prevention drug therapy: can it meet patients’ requirements for reduced risk?
Llewellyn-Thomas HA, Paterson JM, Carter JA, Basinski A, Myers MG, Hardacre GD, Dunn EV, D'Agostino RB, Wolf PA, Naylor CD. Med Decis Making. 2002; 22(4):326-39.
Depression-related short-term disability in an employed population
Dewa CS, Goering P, Lin E, Paterson M. J Occup Environ Med. 2002; 44(7):628-33.